Jennison Associates’s Exelixis EXEL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-164,200
Closed -$3.94M 599
2023
Q4
$3.94M Buy
164,200
+815
+0.5% +$17.7K ﹤0.01% 434
2023
Q3
$3.57M Buy
163,385
+48,870
+43% +$1.02M ﹤0.01% 430
2023
Q2
$2.19M Buy
+114,515
New +$2.21M ﹤0.01% 440
2018
Q3
Sell
-3,194,242
Closed -$68.7M 669
2018
Q2
$68.7M Sell
3,194,242
-2,035,040
-39% -$42.1M 0.07% 209
2018
Q1
$116M Buy
5,229,282
+1,000,521
+24% +$27.7M 0.12% 133
2017
Q4
$129M Buy
4,228,761
+1,167,758
+38% +$31.1M 0.13% 118
2017
Q3
$74.2M Buy
3,061,003
+187,654
+7% +$4.99M 0.08% 210
2017
Q2
$70.8M Buy
2,873,349
+263,135
+10% +$5.57M 0.08% 218
2017
Q1
$56.6M Sell
2,610,214
-195,100
-7% -$3.97M 0.06% 244
2016
Q4
$41.8M Buy
2,805,314
+2,305,314
+461% +$33.3M 0.05% 293
2016
Q3
$6.39M Buy
+500,000
New +$5.41M 0.01% 499
2014
Q1
Sell
-2,205,478
Closed -$13.5M 750
2013
Q4
$13.5M Sell
2,205,478
-413,052
-16% -$2.28M 0.01% 470
2013
Q3
$15.2M Buy
+2,618,530
New +$13.6M 0.02% 457

Other funds holding EXEL

Jennison Associates's EXEL Position: Q1 2024 in Review

Jennison Associates sold out of Exelixis (EXEL) in Q1 2024, closing a stake of 164,200 shares — an estimated $3.94M sold.

Jennison Associates first reported a position in EXEL in Q3 2013 and held it in 13 quarters. The position peaked at $129M in Q4 2017. 422 funds tracked by Wall St. Rank hold EXEL as of Q1 2024.

  • Jennison Associates reported no remaining Exelixis position as of Q1 2024 after selling out during the quarter.
  • Jennison Associates sold 164,200 Exelixis shares in Q1 2024, an estimated $3.94M.
  • Jennison Associates first reported a position in Exelixis in Q3 2013 and held it in 13 quarters.
  • Jennison Associates's Exelixis position peaked at $129M in Q4 2017.
  • 422 funds tracked by Wall St. Rank held Exelixis as of Q1 2024.

Based on Jennison Associates's 13F filing for Q1 2024, filed 2 May 2024.